Aubagio, with the active ingredient teriflunomide, is an oral medication prescribed for the treatment of relapsing forms of multiple sclerosis (MS), a chronic autoimmune disease affecting the central nervous system. It works by modulating the immune system, specifically by inhibiting the activity of certain immune cells that attack the nervous system in MS patients, thereby reducing the frequency of relapse episodes and slowing the progression of physical disability associated with the disease. Aubagio is classified as a disease-modifying therapy (DMT) and is notable for its once-daily oral dosing, offering an alternative to injectable treatments. However, it comes with a range of potential side effects and requires monitoring for liver function and other parameters during treatment.
When using Aubagio, a medication prescribed for the treatment of multiple sclerosis (MS), it's crucial to adhere strictly to your doctor's instructions and thoroughly read the label that accompanies the medicine. Aubagio can cause side effects that may impair your ability to drive or operate machinery safely, such as dizziness or fatigue, so it's important to be cautious until you know how the medication affects you. Common side effects include hair thinning, diarrhea, and liver enzyme elevations, while more rare but serious side effects can include severe liver damage and a decrease in white blood cell count, which can increase the risk of infections. Given Aubagio's potential interactions with other medications, it's essential to inform your doctor about all the medicines you are taking, including over-the-counter drugs and supplements. Monitoring your health and undergoing regular blood tests as recommended by your healthcare provider will help manage any adverse effects promptly. Always prioritize safety and open communication with your healthcare team while on Aubagio therapy.